Lasa Supergenerics Limited (NSE:LASA)
India
· Delayed Price · Currency is INR 7.89
+0.15 (1.94%)
Mar 10, 2026, 10:40 AM IST
Lasa Supergenerics Revenue
Lasa Supergenerics had revenue of 22.17M INR in the quarter ending December 31, 2025, a decrease of -93.33%. This brings the company's revenue in the last twelve months to 669.61M, down -47.77% year-over-year. In the fiscal year ending March 31, 2025, Lasa Supergenerics had annual revenue of 1.47B with 41.20% growth.
Revenue (ttm)
669.61M
Revenue Growth
-47.77%
P/S Ratio
0.59
Revenue / Employee
10.15M
Employees
66
Market Cap
395.30M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivimed Labs | 1.09B |
| Vaishali Pharma | 1.14B |
| Par Drugs and Chemicals | 1.06B |
| Alpa Laboratories | 1.14B |
| Brooks Laboratories | 888.46M |
| Nectar Lifesciences | 16.70B |
| Bafna Pharmaceuticals | 1.47B |
| Valiant Laboratories | 2.03B |